Phibro Animal Health Corporation Announces Closing of Acquisition

Phibro Animal Health Corporation Announces Closing of Acquisition

of Business of MVP Laboratories, Inc.

TEANECK, N.J., January 25, 2016 (GLOBE

NEWSWIRE) - Phibro Animal Health Corporation ("Phibro") (NASDAQ:PAHC) today announced it has completed its

purchase of the assets of MVP Laboratories, Inc. ("MVP"), a developer, manufacturer and marketer of livestock vaccines,

vaccine adjuvants and other products based in Omaha, Nebraska. Phibro previously announced an agreement to purchase the assets

of MVP Laboratories, Inc. on January 12, 2016.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation is a diversified global developer,

manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry,

swine, cattle, dairy and aquaculture. The company reported net sales of $749 million for the fiscal year ended June 30, 2015.

For further information, please visit www.pahc.com.

Phibro Animal Health Corporation

Chief Financial Officer

Forward-Looking Statements

This communication contains forward-looking

statements, which reflect Phibro's current views with respect to business plans or prospects, the transactions described

herein, and other future events. You can identify forward-looking statements by the fact that they do not relate strictly to historical

or current facts. These statements may include words such as "aim," "anticipate," "believe,"

"estimate," "expect," "forecast," "outlook," "potential," "project,"

"projection," "plan," "intend," "seek," "believe," "may,"

"could," "would," "will," "should," "can," "can have,"

"likely," the negatives thereof and other words and terms of similar meaning in connection with any discussion of

the timing or nature of future operating or financial performance or other events. These statements are not guarantees of future

performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties

materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from

those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made.

Phibro expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information,

future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual

Report on Form 10-K and our Quarterly Reports on Form 10-Q, including in the sections thereof captioned "Forward-Looking

Statements" and "Risk Factors." These filings and subsequent filings are available online at www.sec.gov,

www.pahc.com, or on request from Phibro.